Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, is pleased to announce that a current customer has placed an order for use of additional four CADScor Systems to extend the availability of the diagnostic tool across all their locations. This expansion underscores the customer's continued trust in the technology as a valuable solution for early risk assessment of coronary artery disease (CAD).

“We are thrilled to see the continued market confidence in the CADScor System.” said Aamir Mahmood, CEO of Acarix. “The healthcare provider's decision to expand the use of the CADScor System to all of their locations validates the effectiveness of our solution in identifying patients at risk for CAD, and it supports our vision to make early diagnosis more accessible. This expansion is a great example of how our technology is being integrated as a core component in advanced healthcare delivery.”